SPP1 and rheumatoid arthritis: These data, together with the murine RA fracture nonunion model, identify reductions in SPP1 and CXCL12 as the molecular basis for the negative impact of inflammation on angiogenesis and present SPP1 and CXCL12 as potential therapeutic approaches to treat fracture nonunion.